While survivin levels have previously been associated with CAD (4), this novel finding demonstrates that the survivin expression signature of PBMCs may increase collateral formation, potentially providing a valuable prognostic indicator in CAD patients, particularly those with coronary CTO. This evidence concerns the gene BIRC5 and coronary artery disorder.